We are live on
!
Find out more
ORC
O'Rourke & Company Portfolio holdings
AUM
$253M
1-Year Est. Return
16.72%
This Fund
S&P 500
This Quarter
Est. Return
+3.63%
1 Year Est. Return
+16.72%
3 Year Est. Return
+62.38%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$178M
AUM Growth
+$5.42M
(+3.1%)
Cap. Flow
+$136K
Cap. Flow
% of AUM
0.08%
Top 10 Holdings %
Top 10 Hldgs %
41.51%
Holding
146
New
4
Increased
87
Reduced
32
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
|
+$347K |
| 2 |
VPU
Vanguard Utilities ETF
VPU
|
+$302K |
| 3 |
Bristol-Myers Squibb
BMY
|
+$260K |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$255K |
| 5 |
Vanguard Morningstar Small-Cap Value ETF
VBR
|
+$250K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco Preferred ETF
PGX
|
+$1.85M |
| 2 |
GSK
GSK
|
+$864K |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$325K |
| 4 |
United Parcel Service
UPS
|
+$212K |
| 5 |
Dow Inc
DOW
|
+$203K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.43% |
| 2 | Technology | 17.31% |
| 3 | Communication Services | 4.14% |
| 4 | Healthcare | 3.22% |
| 5 | Consumer Discretionary | 2.94% |
Similar funds
RA
N
PI
JWM
ACM
MWM
TODC
MAS
O'Rourke & Company's Q2 2024 Portfolio in Review
As of Q2 2024, O'Rourke & Company held 146 positions worth $178M, up 3.1% from $172M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
O'Rourke & Company's Q2 2024 filing shows 4 new, 87 increased, 32 reduced and 4 closed positions. Its largest new stake was Bristol-Myers Squibb: 5,801 shares worth $241K. The largest sale was Invesco Preferred ETF, an estimated $1.85M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Communication Services.
- O'Rourke & Company's largest Q2 2024 buy was Bristol-Myers Squibb: 5,801 shares worth $241K.
- O'Rourke & Company added most to ProShares S&P 500 Dividend Aristocrats ETF in Q2 2024, an estimated $347K increase.
- O'Rourke & Company's biggest Q2 2024 reduction was Invesco Preferred ETF, cutting an estimated $1.85M.
- O'Rourke & Company fully exited GSK in Q2 2024, selling an estimated $864K.
- O'Rourke & Company's ten largest holdings make up 42% of its $178M portfolio in Q2 2024.
- O'Rourke & Company opened 4 new positions and closed 4 in Q2 2024.
- O'Rourke & Company's portfolio value rose 3.1% quarter-over-quarter to $178M.
Based on O'Rourke & Company's 13F filing for Q2 2024, filed 18 Jul 2024.